Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Tumor With Alterations of the FGF-R × infigratinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 2 Tumor With Alterations of the FGF-R 1 Neoplasm Metastasis 1 Melanoma 1 Lung Neoplasms 1 Glioblastoma 1 Cholangiocarcinoma 1 Breast Neoplasms 1 Advanced Gastrointestinal Stromal Tumor (GIST) 1 Acrocephalosyndactylia 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01697605 2020-12-08

A Phase I Study of Oral BGJ398 in Asian Patients

Novartis

Phase 1 Completed

Tumor With Alterations of the FGF-R

Data powered by HemOnc (CC BY 4.0) Colophon ⚡